The current valuation score of Soligenix Inc is 8.27, ranking 153 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.27, which is -47.32% below the recent high of -0.14 and -648.78% above the recent low of -2.05.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.